Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
SANTARUS Add to My Watchlist (NSDQ: SNTS) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Santarus 3.70 -0.01 (-0.27%) 246,512
3721 Valley Centre Drive
Suite 400
San Diego, CA 92130 US
(858) 314-5700
(858) 314-5701 fax
www.santarus.com
CEO Gerald T. Proehl
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US8028173040
CIK Number 1172480
NAICS Code 325412
Business Summary
A specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians.
Number of Employees 345
Share Fundamentals
Market Cap 214.88M
Shares Outstanding 58.08M
Float 57.39M
Short Interest 1.83M
Financial Strength
Revenue (TTM) $147,631,000
Earnings (TTM) -$2,537,000
Quick Ratio 1.2:1
Current Ratio 1.3:1
Total Debt/Equity 0.48:1
Profitability
Gross Margin 87.5%
EBITDA Margin 0.3%
Profit Margin -1.1%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs